Posted by Clinical Lab Products | Dec 22, 2009 | Miscellaneous |
Rates of 2009 H1N1 influenza virus testing in the US have declined more than 75% since their peak in late October, suggesting that the second wave of virus infection may be coming to an end, according to a new report by Quest Diagnostics.
Read MorePosted by Clinical Lab Products | Dec 17, 2009 | Company News, Sexually Transmitted Diseases |
Tibotec Virco Virology BVBA has announced the acquisition of LAB TRACKER HIV, a customized electronic medical record (EMR) system, from the company Ground Zero Software.
Read MorePosted by Clinical Lab Products | Dec 7, 2009 | Miscellaneous |
C3-Jian Inc and Matrix Sensors Inc have announced a collaboration in which engineered peptides from C3-Jian will be used on Matrix Sensors’ microchip molecular detector arrays, allowing initial evaluation of a diagnostic assay platform for commercial use.
Read MorePosted by Clinical Lab Products | Nov 30, 2009 | Miscellaneous |
Gen-Probe Inc has announced that the FDA has cleared for marketing Prodesse’s ProParaflu+ assay, a molecular test that detects and differentiates parainfluenza 1, 2 and 3 viruses, which cause lower respiratory tract infections.
Read MorePosted by Clinical Lab Products | Nov 23, 2009 | Miscellaneous |
Rates of infection by the 2009 H1N1 influenza virus may have peaked in late October, but the pandemic flu virus continues to be a potential source of illness in all age groups, including the elderly, according to a new report by Quest Diagnostics.
Read More